commissioning outcomes

News

NHS broadens access to haemophilia A drug Hemlibra

More people living with haemophilia A will be able to get access to Roche/Chugai's Hemlibra thanks to a commissioning agreement with NHS England.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Debates & Insight

UK pharma and integrated health

The concept of integrated healthcare is not new to the UK, where it has been discussed since the late 1960s.

R&D

Allogeneic cell therapy isn’t dead, with Brian Culley

Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks